Aurinia Pharmaceuticals Inc. (AUPH)
NASDAQ: AUPH · Real-Time Price · USD
15.25
-0.71 (-4.45%)
At close: Jul 20, 2026, 4:00 PM EDT
15.30
+0.05 (0.33%)
After-hours: Jul 20, 2026, 7:54 PM EDT
Aurinia Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 7 analysts polled by S&P Global, Aurinia Pharmaceuticals stock has a consensus rating of "Buy" and an average price target of $17. The average 1-year stock price forecast is 11.48% higher than the current stock price, while the lowest is $15 (-1.64%) and the highest is $21 (+37.70%).
Price Target: $17 (+11.48%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Aurinia Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 3 | 3 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 7 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| TD Cowen | TD Cowen | Buy Maintains $17 | Buy | Maintains | $17 | +11.48% | Jul 6, 2026 |
| Bloom Burton | Bloom Burton | Hold Maintains $15 | Hold | Maintains | $15 | -1.64% | May 11, 2026 |
| RBC Capital | RBC Capital | Hold Reiterates $15 | Hold | Reiterates | $15 | -1.64% | May 8, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $17 | Buy | Reiterates | $17 | +11.48% | Feb 27, 2026 |
Financial Forecast
Revenue This Year
324.39M
from 283.06M
Increased by 14.60%
Revenue Next Year
386.92M
from 324.39M
Increased by 19.28%
EPS This Year
0.96
from 2.07
Decreased by -53.62%
EPS Next Year
1.12
from 0.96
Increased by 16.46%
EPS and Forward PE are based on non-GAAP adjusted numbers.